Photo: REUTERS
Actavis said Monday it would acquire Allergan for a stock and cash deal totaling about $66 billion, or $219 per share, creating a top 10 global pharma giant.
Actavis (NYSE:ACT) is up $8.33, or around 3.5 percent on the heels of the news, while Allergan (NYSE:AGN) is up 13.20, or around 6.6 percent.
